
- Pharmaceutical Commerce - January/February 2009
Chapter closes on trial of Georgia distributor of knockoff branded products
Company imported knockoffs from Belize and sold them over the Internet
As reported by MSNBC, Jared Wheat, president of Hi-Tech Pharmaceuticals (Norcross, GA) accepted a plea bargain in federal court for illegally selling the drugs, and will serve a 50-month sentence. The company and other individual defendants will forfeit $3 million in illicit proceeds. However, charges from other alleged actions, including racketeering, and selling diet supplements spiked with ephendrine, were dropped.
Stemming from investigations that concluded with arrests in 2006, Hi-Tech was accused of running a manufacturing facility in Belize from which it imported “generic” versions of Xanax, Valium, Ambien, Zoloft and other branded products. In interviews with MSNBC, West had contended that the products were legal because patent protections for them did not exist in Belize.
Articles in this issue
over 16 years ago
Closing The Circle On Patient Adherenceover 16 years ago
3PLs Rise in Forward-Thinking Supply Chain Modelsover 16 years ago
A Pitched Battle in Cardiovascular Drug Marketingover 16 years ago
Wyeth Loses Supreme Court Case Over 'Implied' Pre-Emptionover 16 years ago
Syringe Design Gets a Makeoverover 16 years ago
Refinements in Cold Chain Secondary Packagingover 16 years ago
Inmar Rebrands Reverse-Logistics and Related Business Unitsover 16 years ago
The Packaging Contribution to Patient Adherenceover 16 years ago
Moving the Dial on Patient AdherenceNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





